The DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index, and 1 are not checked yet.
Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Open accessAbstract
GABAA (γ-aminobutyric acid, type A) receptors are a family of ligand-gated ion channels that are essential for the regulation of central nervous system function. Benzodiazepines — which non-selectively target GABAA receptors containing the α1, α2, α3 or α5 subunits — have been in clinical use for decades and are still among the most widely prescribed drugs for the treatment of insomnia and anxiety disorders. However, their use is limited by side effects and the risk of drug dependence. In the past decade, the identification of separable key functions of GABAA receptor subtypes suggests that receptor subtype-selective compounds could overcome the limitations of classical benzodiazepines; furthermore, they might be valuable for novel indications such as chronic pain, depression, schizophrenia, cognitive enhancement and stroke.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since benzodiazepines enhance the effect of GABA on GABAA receptors 72 ,”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Cortical inhibitory neurons and schizophrenia
Lewis, D. A., Hashimoto, T., & Volk, D. W. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1648 · Cited by 2,297 · cited 1×
“In post-mortem brain from patients with schizophrenia, there is an upregulation of the α2 subunit in the axon initial segments of these pyramidal neuron”
BackgroundBenzodiazepine Receptor: Demonstration in the Central Nervous System
Möhler, H., & Okada, T. (1977) · Science · doi:10.1126/science.918669 · Cited by 1,709 · cited 1×
“Benzodiazepines have been shown to bind to specific sites in the central nervous syste”
BackgroundNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589 · cited 1×
“Although there is tremendous interest in developing antidepressant agents that utilize different mechanisms of action, the development of such agents has not yet been successfu”
BackgroundBenzodiazepine receptors in rat brain
Squires, R. F., & Bræstrup, C. (1977) · Nature · doi:10.1038/266732a0 · Cited by 1,453
GABAA receptors: immunocytochemical distribution of 13 subunits in the adult rat brain
Pirker, S., Schwarzer, C., Wieselthaler, A., Sieghart, W., & Sperk, G. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00442-5 · Cited by 1,344
Fritschy, J., & Mohler, H. (1995) · Journal of Comparative Neurology · doi:10.1002/cne.903590111 · Cited by 1,244
Benzodiazepine actions mediated by specific γ-aminobutyric acidA receptor subtypes
Rudolph, U., Crestani, F., Benke, D., Brünig, I., Benson, J. A., Fritschy, J.-M., Martin, J. R., Bluethmann, H., & Möhler, H. (1999) · Nature · doi:10.1038/44579 · Cited by 1,172
Self-citationOlsen, R. W., & Sieghart, W. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00505 · Cited by 1,064
Regulation of firing of dopaminergic neurons and control of goal-directed behaviors
Grace, A. A., Floresco, S. B., Goto, Y., & Lodge, D. J. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.03.003 · Cited by 1,034 · cited 1×
“, activates tonic firing of dopaminergic neurons in the midbrain; this circuit involves glutamatergic neurons in the hippocampus, GABAergic neurons in the nucleus accumbens and GABAergic neurons in the ventral pallidu”
Background
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 745
Mahmoodkhani, M., Ghasemi, M., Derafshpour, L., Amini, M., & Mehranfard, N. (2020) · Developmental Neuroscience · doi:10.1159/000512221 · Cited by 11
Kaczor, P. T., Michałowski, M. A., & Mozrzymas, J. W. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00401 · Cited by 11
Groenink, L., Verdouw, P. M., Zhao, Y., ter Heegde, F., Wever, K. E., & Bijlsma, E. Y. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06307-1 · Cited by 13
“On the one hand, attempts have been made to synthesize drugs that would interact more selectively (e.g., TPA023) or with lower efficacy (e.g., bretaze-nil) with the GABA A receptor complex to overcome the adverse effects of prototypical benzodiazepines (Rudolph and Knoflach 2011).”
BackgroundLingford-Hughes, A. R., Myers, J. F., Watson, B. J., et al. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.02.005 · Cited by 11
“There is evidence that the α1, α2 and α5 subtypes contribute to drug-liking and/or drug-seeking in a variety of preclinical models with a range of substances of abuse (Rudolph and Knoflach, 2011; Engin et al., 2012; Dixon et al., 2010; June et al., 2001).”
Designer Benzodiazepines: Effects, Toxicity, and Interactions
Balkhi, S. E., & Abbara, C. (2023) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001071 · Cited by 10
Hondebrink, L., Hermans, E., Schmeink, S., et al. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.09.002 · Cited by 10
“Most currently used medicines that exert their effect amongst others via the GABAA-R are known to act as allosteric agonists on the GABA-R; they enhance the effect of GABA on the receptor and thus decrease neurotransmission (for review see D’Hulst et al., 2009; Rudolph and Knoflach, 2011).”
BackgroundZabela, V., Hettich, T., Schlotterbeck, G., Wimmer, L., Mihovilovič, M. D., Guillet, F., Bouaita, B., Shevchenko, B., Hamburger, M. O., & Oufir, M. (2017) · Journal of Chromatography B · doi:10.1016/j.jchromb.2017.11.036 · Cited by 10
Çomaklı, S., Özdemir, S., & Değirmençay, Ş. (2020) · Archives of Virology · doi:10.1007/s00705-020-04617-3 · Cited by 10
The seizure‐inducing plastic explosive RDX inhibits the α1β2γ2 GABAA receptor
Pressly, B., Lee, R. D., Singh, V., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51536 · Cited by 10
Coppola, L., & Montanaro, F. (2013) · Homeopathy · doi:10.1016/j.homp.2013.07.002 · Cited by 10
Gupta, R. (2017) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2017/26414.10381 · Cited by 10
Deplanque, D., Machuron, F., Waucquier, N., Jozefowicz, E., Duhem, S., Somers, S., Colin, O., Duhamel, A., & Bordet, R. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.05.011 · Cited by 10
“Furthermore, the α1 and α5 subunit binding by classical BZDs, such as diazepam, bromazepam and lorazepam, may contribute to their unwanted effects including withdrawal symptoms, sedation, amnesia and cognitive impairments ( Rudolph and Knoflach, 2011 ).”
BackgroundAnalysis of GABRG2 C588T polymorphism in genetic epilepsy and evaluation of GABRG2 in drug treatment
Wang, S., Zhang, X., Zhou, L., Wu, Q., & Han, Y. (2021) · Clinical and Translational Science · doi:10.1111/cts.12997 · Cited by 10
Ashton, M. K., Rueda, A. V. L., Ho, A. M., Aizin, N. A. B. M. N., Sharma, H., Dodd, P. R., Stadlin, A., & Camarini, R. (2022) · Genes Brain & Behavior · doi:10.1111/gbb.12785 · Cited by 11
Treatment-resistant insomnia treated with pregabalin.
Iorio, G. D., Matarazzo, I., Tizio, L. D., et al. (2013) · PubMed · Cited by 10
The Effect of Matricaria Chamomilla on Sleep Quality of Elderly People Admitted to Nursing Homes
Abdullahzadeh, M., & Naji, S. (2014) · Iran Journal of Nursing · doi:10.29252/ijn.27.89.69 · Cited by 10
Morse, B. L., Chadha, G., Felmlee, M. A., Follman, K. E., & Morris, M. E. (2017) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2017.1339055 · Cited by 10
“exist, less is known about the heterogeneity of GABAB receptors (41,42).”
BackgroundKu, S.-C., Ho, P., Tseng, Y., Yeh, T., Cheng, S.-L., & Liang, C. (2018) · Psychiatry Investigation · doi:10.30773/pi.2018.05.02.1 · Cited by 10
Nardi, L., Chhabra, S., Leukel, P., Krueger‐Burg, D., Sommer, C., & Schmeißer, M. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1199097 · Cited by 11
“GABAA receptors, which contain the δ subunit, are only 5% of the total, are located perior extrasynaptically and mediate tonic inhibition (18, 81).”
BackgroundBenzodiazepines and Anxiety Disorders: From Laboratory to Clinic
Samardžić, J., & Štrac, D. Š. (2016) · InTech eBooks · doi:10.5772/64959 · Cited by 11
“A receptor subtypes responsible for various pharmacological effects of BDZs ( Table 1 ) [97, 98].”
Alijanpour, S., Jafaripour, S., Ghasemzadeh, Z., Khakpai, F., & Zarrindast, M. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173806 · Cited by 9
Hernández‐Martín, E., Vidmark, J. S. L., MacLean, J. A., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1215572 · Cited by 9
Fischer, B. D., Platt, D. M., Rallapalli, S., Namjoshi, O. A., Cook, J. M., & Rowlett, J. K. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.10.026 · Cited by 9
“These same receptors also mediate other characteristic effects that limit the use of benzodiazepines, such as daytime drowsiness, impairment of motor coordination, and deficits in memory (for review, see Rudolph and Knoflach, 2011).”
BackgroundInfluentialFurukawa, Y., Tanemura, K., Igarashi, K., Ideta-Otsuka, M., Aisaki, K., Kitajima, S., Kitagawa, M., & Kanno, J. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00339 · Cited by 9
“R α1 and γ2 subtypes (Rudolph and Knoflach, 2011).”
Behnke, G., Tiscione, N. B., Rakus, J. F., et al. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz010 · Cited by 9
McCusker, P., Mian, M. Y., Li, G., et al. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007826 · Cited by 9
“This has enabled the design of various benzodiazepines with reduced affinity towards α1-containing GABAARs to treat conditions such as asthma and schizophrenia that involve GABAARs that contain other α [20].”
BackgroundFabjan, J., Koniuszewski, F., Schaar, B., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.611953 · Cited by 9
Rahman, M. A., Keck, T. M., Poe, M. M., Sharmin, D., Cook, J. M., & Fischer, B. D. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05791-1 · Cited by 9
Muscle power during intravenous sedation
Matsuura, N. (2017) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2017.02.001 · Cited by 9
Zhu, T., Yan, Y., Deng, S., Liu, Y., Fan, H.-R., Ma, B., Meng, B., Mei, B., Li, W., & Li, F. R. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.034 · Cited by 9
“…in CeL for mediating the effects of ME in counteracting anorexigenic signals, we generated an AAV construct that expresses a short hairpin RNA (shRNA) targeting the γ2 subunit of GABAARs, which is present in approximately 90% of GABAARs (Rudolph and Knoflach, 2011), driven by the U6 promoter (Fig.”
InfluentialBenzodiazepine Site Agonists Differentially Alter Acetylcholine Release in Rat Amygdala
Hambrecht‐Wiedbusch, V. S., Mitchell, M. F., Firn, K. A., Baghdoyan, H. A., & Lydic, R. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000201 · Cited by 9
Neuroprotective Effects of Flavonoids in Epilepsy
Hosseinzadeh, H., & Nassiri‐Asl, M. (2017) · doi:10.1002/9783527803781.ch10 · Cited by 9
Effects of diazepam on hippocampal blood flow in people at clinical high risk for psychosis
Livingston, N. R., Kiemes, A., Devenyi, G. A., Knight, S., Lukow, P. B., Jelen, L. A., Reilly, T. J., Dima, A., Nettis, M. A., Casetta, C., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01864-9 · Cited by 10
“The reductions in rCBF observed in further cortical regions may be related to the ubiquitous binding pro fi le of benzodiazepines. α 1 – α 3 receptor subunits, implicated in benzodiazepine-related side effects such as sedation and addiction, show widespread cortical distribution [81].”
BackgroundAnthwal, T., Pant, S., Rana, P., et al. (2025) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1515866 · Cited by 8
Wang, S., Liu, H., Lei, K., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104182 · Cited by 8
CGP7930 - An allosteric modulator of GABABRs, GABAARs and inwardly-rectifying potassium channels
Hannan, S. B., Penzinger, R., Mickute, G., & Smart, T. G. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109644 · Cited by 8
Crow, J. M. (2013) · Nature · doi:10.1038/497s16a · Cited by 8
Lorediplon: A New GABAA Modulator Drug for Treatment of Insomnia
Aniello, F. D., Santos, B., & Guglietta, A. (2014) · Milestones in drug therapy · doi:10.1007/978-3-319-11514-6_6 · Cited by 8
Tian, Y., Chen, S., & Shan, Q. (2020) · The Journal of Physiology · doi:10.1113/jp279288 · Cited by 8
“…anti-emetics, sedatives, anti-convulsants, anxiolytics, general anaesthetics and anti-parasitics (Wolstenholme & Rogers, 2005; Taly et al. 2009; Walstab et al. 2010; Rudolph & Knoflach, 2011; Dineley et al. 2015; Olsen, 2018), knowledge of their structure and function has long been pursued.”
BackgroundAranđelović, J., Santrač, A., Batinić, B., Todorović, L., Khan, M. Z. A., Rashid, F., Poe, M. M., Obradović, A. L., Cook, J. M., & Savić, M. M. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215079 · Cited by 8
“On the other hand, the selected gene expression receptor repertoire (GABRA2, GABRA3, and GABRA5) plays a role in emotions and/or mood control with potential for therapeutic manipulation [33, 34].”
Uzzaman, M., Ahsan, A., & Uddin, M. N. (2021) · European Journal of Chemistry · doi:10.5155/eurjchem.12.4.412-418.2135 · Cited by 8
Kumar, M., González, L. A., & Dillon, G. H. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.007 · Cited by 8
“…broader collection of GABAAR subtypes (Licata and Rowlett, 2008), the high efficacy of carisoprodol for both direct and allosteric effects on α1-containing receptors, coupled with its ability to interact with GABAAR subtypes, is consistent with its high abuse potential (Rudolph and Knoflach, 2011).”
BackgroundInfluentialReceptor and Channel Heteromers as Pain Targets
Berg, K. A., Patwardhan, A. M., & Akopian, A. N. (2012) · Pharmaceuticals · doi:10.3390/ph5030249 · Cited by 8
Straub, C. J., Lau, H. M., Parlato, R., Schuetz, G., Fritschy, J., & Rudolph, U. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182800d76 · Cited by 9
“Medetomidine was chosen for two reasons: (1) Essential pharmacologically relevant data, for example, with respect to binding to α2-adrenergic receptor subtypes were not available for xylazine, and (2) there is a significant body of experimental studies on the sedative, hypnotic, and hypothermic actions with medetomidi…”
InfluentialSelf-citationKlein, A. B., Nittegaard-Nielsen, M., Christensen, J. T., et al. (2015) · MedChemComm · doi:10.1039/c5md00442j · Cited by 8
Lazo-Gómez, R., & Tapia, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00200 · Cited by 8
Knoflach, F., Hernandez, M., & Bertrand, D. (2018) · Journal of Visualized Experiments · doi:10.3791/57842 · Cited by 8
Self-citationThe role of loops B and C in determining the potentiation of GABA A receptors by midazolam
Moody, O. A., & Jenkins, A. (2018) · Pharmacology Research & Perspectives · doi:10.1002/prp2.433 · Cited by 8
“For example, nonhypnotic drugs targeting the α2 and α3 subunits have been studied for their anxiolytic and analgesic effects.(41,45) However, creating ligands that distinguish these two subunits remains difficult, as shown when an MOODY AND JENKINS | 9 of 11”
BackgroundCiraulo, D. A., & Oldham, C. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00016-2 · Cited by 8
Neuronal Networks Regulating Sleep and Arousal: Effect of Drugs
Szabadi, E. (2014) · Milestones in drug therapy · doi:10.1007/978-3-319-11514-6_2 · Cited by 9
“Extrasynaptic GABAA receptors mediate a slow tonic inhibitory response (Winsky-Sommerer 2009; Rudolph and Knoflach 2011).”
BackgroundDamgaard, M., Al-Khawaja, A., Nittegaard-Nielsen, M., Petersen, R. F., Wellendorph, P., & Frølund, B. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.024 · Cited by 8
Neugebauer, N. M., Miyauchi, M., Sato, T., Tadano, J., Akal, H., Ardehali, H., & Meltzer, H. Y. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.033 · Cited by 7
González‐Burgos, G., Miyamae, T., Reddy, N., Dawkins, S., Chen, C., Hill, A., Enwright, J. F., Ermentrout, B., & Lewis, D. A. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhad077 · Cited by 9
Cerne, R., Smith, J. L., Chrzanowska, A., & LIPPA, A. S. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173895 · Cited by 8
Treviño, M., Guerra‐Crespo, M., Padilla-Godínez, F. J., Soto-Rojas, L. O., Manjarrez, E., Ortega‐Robles, E., Rodríguez-de-Ita, J., & Arias-Carrión, Ó. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1697905 · Cited by 7
“Subtype-selective ligands targeting α 2-or α 3-containing receptors demonstrate anxiolytic ef fi cacy without the sedative pro fi le of classical benzodiazepines (Rudolph and Kno fl ach, 2011).”
Effects of Diazepam on Reaction Times to Stop and Go
Sarkar, S., Choudhury, S., Islam, N., Chowdhury, M. S. J. H., Chowdhury, M. T. I., Baker, M. R., Baker, S. N., & Kumar, H. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.567177 · Cited by 8
“Long term use of diazepam has been associated with cognitive impairment, presumably as a side effect of the non-selective binding to all synaptic GABAA subtypes (Rudolph and Knoflach, 2011).”
BackgroundZhang, L., Shi, W., Liu, J., Chen, K., Zhang, G., Zhang, S., Cong, B., & Li, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612985 · Cited by 7
Ajiboye, B. O., Famusiwa, C. D., Falode, J. A., et al. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100548 · Cited by 7
Identification of amino acids involved in histamine potentiation of GABAA receptors
Thiel, U., Platt, S. J., Wolf, S., Hatt, H. H., & Gisselmann, G. ⁄. N. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00106 · Cited by 7
“ORIGINAL RESEARCH published: 26 May 2015 doi: 10.3389/fphar.2015.00106 Edited by: Jean-François Desaphy, University of Bari Aldo Moro, Italy Reviewed by: Oscar Moran, Consiglio Nazionale delle Ricerche, Italy Christoph Fahlke, Forschungszentrum Jülich, Germany *Correspondence: Günter Gisselmann, Department of Cell Phy…”
InfluentialGABAergic neurotransmission alterations in autism spectrum disorders
Sesarini, C. V. (2015) · Neurotransmitter · doi:10.14800/nt.1052 · Cited by 8
Guerrini, G., Ciciani, G., Crocetti, L., Daniele, S., Ghelardini, C., Giovannoni, M. P., Mannelli, L. D. C., Martini, C., & Vergelli, C. (2017) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.2882 · Cited by 7
Natural product incarvillateine aggravates epileptic seizures by inhibiting GABAA currents
Bian, X., Zhang, Y., Huang, B., Wang, X., Wang, G., Zhu, Y., Liu, Y., Liang, J., Jia, Y., & Wang, K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172496 · Cited by 7
Головенко, М. Я. (2021) · Visnik Nacional noi academii nauk Ukrai ni · doi:10.15407/visn2021.04.076 · Cited by 7
Non-Opioid Anesthetics Addiction: A Review of Current Situation and Mechanism
Deng, L., Wu, L., Gao, R., Xu, X., Chen, C., & Liu, J. (2023) · Brain Sciences · doi:10.3390/brainsci13091259 · Cited by 9
“BDZs bind to a pocket formed by the α and the γ subunits [131,135].”
BackgroundHeidelberg, L. S., Warren, J., & Fisher, J. L. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207324 · Cited by 7
“the occurrence of unwanted effects such as sedation (Rudolph and Knoflach, 2011).”
BackgroundClosing the Gap Between the Molecular and Systemic Actions of Anesthetic Agents
Antkowiak, B. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.10.009 · Cited by 8
Analysis of Differential Efficacy and Affinity of GABAA(α1/α2) Selective Modulators
Ain, Q. U., Owen, R. M., Omoto, K., Torella, R., Bulusu, K. C., Pryde, D. C., Glen, R. C., Fuchs, J. E., & Bender, A. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00813 · Cited by 7
Söderhielm, P. C., Balle, T., Bak-Nyhus, S., Zhang, M., Hansen, K. M., Ahring, P. K., & Jensen, A. A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.08.019 · Cited by 7
Nikolaus, M., Kreye, J., Turko, P., et al. (2018) · Brain Research · doi:10.1016/j.brainres.2018.10.019 · Cited by 7
Nelson, T. S., Holstein, S. E., Baird, J.-P., & Pittman, D. W. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.040 · Cited by 7
“Benzodiazepines bind at the α1, α2, α3, α5 (not α4 or α6), and the γ2 (not γ1 or γ3) subunits (Rudolph and Knoflach, 2011).”
A FLIPR Assay for Discovery of GABAA Receptor Modulators of Natural Origin
Faleschini, M. T., Maier, A., Fankhauser, S. C., et al. (2019) · Planta Medica · doi:10.1055/a-0921-7602 · Cited by 7
“However, currently used drugs lack receptor subtype selectivity and, therefore, exhibit side effects such as unwanted sedation, addiction, and relapse into insomnia upon drug withdrawal [3, 6,7, 9].”
BackgroundAmrutkar, D. V., Dyhring, T., Jacobsen, T. A., Larsen, J. S., & Sandager‐Nielsen, K. (2020) · The Cerebellum · doi:10.1007/s12311-020-01106-w · Cited by 7
Molecular Mechanisms of Depression: The Interplay Between Genes and Receptors
Oatu, A., Trifu, S. C., & Coman, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311325 · Cited by 8
“These α 5-selective modulators offer potential for developing non-sedating anxiolytics and cognitive enhancers with fewer side effects than classical benzodiazepines [113].”
The role of GABAA receptors in hippocampus-dependent cognitive functions
Nagarajan, R., Lyu, J., George, J. C., Rudolph, U., & Engin, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106659 · Cited by 8
Self-citationXin, Y., Chu, T., Zhou, S., & Xu, A. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110821 · Cited by 6
“Benzodiazepines have binding sites between the alpha subunit ( α 1 – 3, α 5) and the gamma subunit (usually γ 2), but GABA A receptors containing α 4 or α 6 subunits do not bind to clinically used classical benzodiazepines (Rudolph and Knoflach, 2011).”
BackgroundCasagrande, S., Zuliani, L., & Grisold, W. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00019-0 · Cited by 6
New Insights Into Pharmacology of GABAA Receptor Alpha Subunits–Selective Modulators
Moraru, M. V., Stoleru, S., Zugravu, A., Coman, O. A., & Fulga, I. (2024) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001810 · Cited by 6
“4,5 These attempts are bringing optimism for more precise and safer treat-ment options.”
Zhang, M., Zhao, J., Ji, H., Tan, Y., Zhou, S., Sun, J., Ding, Y., & Li, X. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03299-2 · Cited by 7
“Current researches indicated that DBI was associated with some mental disorders like anxiety and autism spectrum disorder [40 – 42].”
Rösner, S., Soyka, M., Hajak, G., Wehrle, R., & Englbrecht, C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010701 · Cited by 6
Dell’Olio, F., Capodiferro, S., Lorusso, P., et al. (2019) · Cureus · doi:10.7759/cureus.6508 · Cited by 6
Hirose, M., Nakamura, T., Watanabe, A., Esaki, Y., Koike, S., Yamamoto, Y., Iwata, N., & Kitajima, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.933690 · Cited by 6
Warlick, H., Leon, L., Patel, R., Filoramo, S., Knipe, R., Joubran, E., Levy, A., Nguyen, H., & Rey, J. A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08110-9 · Cited by 6
“L-838,417 has been shown to maintain BZD-like anxiolysis while limiting amnesia and ataxia [17].”
BackgroundSzabó, G., Károlyi, B. I., Vaskó, Á. G., et al. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00608 · Cited by 6
Benzodiazepines use and mortality in chronic heart failure
Ribeirinho-Soares, P., MADUREIRA, S., Elias, C., Gouveia, R., Neves, A., Amorim, M., Carreira, M., Pereira, J. B., Almeida, J., & Lourenço, P. (2023) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16464 · Cited by 6
Ismail, F. S., & Faustmann, P. M. (2023) · Epilepsia Open · doi:10.1002/epi4.12750 · Cited by 5
Du, Y., Li, J., Wang, M., Tian, Q., Pang, Y., Wen, Y., Wu, D., Wang, Y. T., & Dong, Z. (2023) · MedComm · doi:10.1002/mco2.235 · Cited by 6
Gunter, B. W., Platt, D. M., & Rowlett, J. K. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.08.003 · Cited by 6
Ren, Y., Xie, R., Marshall, S. F., Li, L., Zhou, T., & Lu, W. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1918-8 · Cited by 6
“The BZDs, acting as positive allosteric modulators of gamma-amino butyric acid-A (GABAA) receptor, could bind at a specific site formed between one α subunit and γ subunit and enhance the inhibitory response to gamma-amino butyric acid (GABA) [1, 2].”
BackgroundFast-Acting Sublingual Zolpidem for Middle-of-the-Night Wakefulness
Pergolizzi, J. V., Taylor, R., Raffa, R. B., Nalamachu, S. R., & Chopra, M. (2014) · Sleep Disorders · doi:10.1155/2014/527109 · Cited by 6
“Genetic studies of knock-in mice suggest the main target of zolpidem, GABAA receptors with α1 subunits, are involved in sedative action, while GABAA receptors with other subunits are associated with a variety of other activities, such as anxiety, myorelaxation, and cognitive function [16].”
BackgroundGhisdal, P., Noël, N., Pacico, N., et al. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113501555 · Cited by 6
Fukami, Y., Okada, H., Yoshida, M., et al. (2017) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001038 · Cited by 6
Payghan, P. V., Bera, I., Bhattacharyya, D., & Ghoshal, N. (2018) · Frontiers in Physics · doi:10.3389/fphy.2018.00052 · Cited by 7
“Human brain contains 20–30% GABAergic neurons [32], where GABA mainly acts through ionotropic (GABAA, GABAC) and metabotropic (GABAB) receptors.”
BackgroundInfluentialMatthey, A., Daali, Y., Curtin, F., Poncet, A., Desmeules, J. A., & Besson, M. J. (2020) · European Journal of Pain · doi:10.1002/ejp.1554 · Cited by 6
“Until recently, these selective GAMs failed very early in clinical development (Rudolph & Knoflach, 2011).”
BackgroundLin, C., Ma, D., Song, X., Zhao, T., Shi, Z., Ling, N., Qin, J., Zhou, Q., Wu, L., & Wang, Y. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220310115846 · Cited by 6
Rohbeck, E., Hasse, B., Koopmans, G. C., Romero, A., Belgardt, B., Roden, M., Eckel, J., & Romacho, T. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14719 · Cited by 6
Nutraceuticals in anxiety and stress
Srivastava, A., & Kumar, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821038-3.00004-5 · Cited by 6
Gatta, E., Cupello, A., Braccio, M. D., Grossi, G., Robello, M., Scicchitano, F., Russo, E., & Sarro, G. D. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0838-0 · Cited by 6
“Anticonvulsive action”
BackgroundKim, D., Choi, G., Kim, S., Kim, J., Oh, D., Tatsuzaki, J., Yang, J., & Cho, S. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120008 · Cited by 5
A High-Throughput Behavioral Assay for Screening Novel Anxiolytics in Larval Zebrafish
Dang, A., Zhao, G., Xu, J., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18070968 · Cited by 5
“BZDs act as positive allosteric modulators at GABA A receptors, rapidly reducing anxiety but are associated with sedation, psychomotor impairment, tolerance, and dependence with chronic use [4].”
Wu, Y., Yao, C., Zhang, L., & Wu, G. (2024) · Neuroreport · doi:10.1097/wnr.0000000000001999 · Cited by 5
“Hypnotic agents including antidepressants, benzodiaz-epines, and antihistamines are most frequently used for anti-insomnia [10], long-term use of which leads to tolerance and dependence, contributing to withdrawal syndrome after drug discontinuation [11].”
Background
Metadata
- Authors
- Rudolph, U., & Knoflach, F.
- Affiliations
- Harvard University (US)
- F. Hoffmann-La Roche AG (CH)
- Corresponding author
- Rudolph, Uwe
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-07-29
- Volume
- 10
- Issue
- 9
- Pages
- 685-697
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3375401
- OpenAlex
- W2013775967
- Semantic Scholar
- bfb4fcd647899053b94eaf5edf1fe9e748076c6b
- Cited by
- 733
- References
- 111
- Citations by year
- 2026: 41 · 2025: 42 · 2024: 35 · 2023: 46 · 2022: 43 · 2021: 55 · 2020: 49 · 2019: 56 · 2018: 51 · 2017: 58 · 2016: 52 · 2015: 45 · 2014: 62 · 2013: 58 · 2012: 38
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R21MH087829, R01MH080006, R03MH085149, MH087829, MH085149, MH080006)
- National Institute on Drug Abuse (DA027051, DA026578, R03DA026578, R03DA027051)
- National Institute of General Medical Sciences (R01GM086448, GM086448)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- GABAA receptor, benzodiazepines, GABAA receptor subtypes, ligand-gated ion channels, chronic pain, depression, schizophrenia, cognitive enhancement, stroke, drug addiction
- MeSH terms
- Analgesics, Animals, Anxiety Disorders, Benzodiazepines, Depressive Disorder, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Mutation, Receptors, GABA-A, Schizophrenia, Nootropic Agents, GABA Modulators, Substance-Related Disorders, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review